🚀 VC round data is live in beta, check it out!
Vimab Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vimab Group and similar public comparables like Digital Research Company, Convalue, Dovre Group, Nepa and more.
Vimab Group Overview
About Vimab Group
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
Founded
1983
HQ
Employees
212
Website
Sectors
Financials (FY)
EV
$19M
Vimab Group Financials
Vimab Group reported last fiscal year revenue of $34M and negative EBITDA of ($4M).
In the same fiscal year, Vimab Group generated $24M in gross profit, ($4M) in EBITDA losses, and had net loss of ($11M).
Vimab Group P&L
In the most recent fiscal year, Vimab Group reported revenue of $34M and EBITDA of ($4M).
Vimab Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $34M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $24M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 69% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (11%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (25%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($11M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (32%) | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vimab Group Stock Performance
Vimab Group has current market cap of $12M, and enterprise value of $19M.
Market Cap Evolution
Vimab Group's stock price is $0.25.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $12M | 0.3% | XXX | XXX | XXX | $-0.23 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVimab Group Valuation Multiples
Vimab Group trades at 0.6x EV/Revenue multiple, and (4.9x) EV/EBITDA.
Vimab Group Financial Valuation Multiples
As of April 20, 2026, Vimab Group has market cap of $12M and EV of $19M.
Equity research analysts estimate Vimab Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vimab Group has a P/E ratio of (1.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12M | XXX | $12M | XXX | XXX | XXX |
| EV (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.9x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.8x | XXX | XXX | XXX |
| P/E | — | XXX | (1.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (8.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vimab Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vimab Group Margins & Growth Rates
Vimab Group's revenue in the last fiscal year declined by (3%).
Vimab Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Vimab Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (11%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 140% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 94% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Vimab Group Public Comps
See public comps and valuation multiples for other Business Consulting comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Vimab Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Digital Research Company | XXX | XXX | XXX | XXX | XXX | XXX |
| Convalue | XXX | XXX | XXX | XXX | XXX | XXX |
| Dovre Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Nepa | XXX | XXX | XXX | XXX | XXX | XXX |
| Investimentos Bemge | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vimab Group M&A Activity
Vimab Group acquired XXX companies to date.
Last acquisition by Vimab Group was on XXXXXXXX, XXXXX. Vimab Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Vimab Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVimab Group Investment Activity
Vimab Group invested in XXX companies to date.
Vimab Group made its latest investment on XXXXXXXX, XXXXX. Vimab Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Vimab Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vimab Group
| When was Vimab Group founded? | Vimab Group was founded in 1983. |
| Where is Vimab Group headquartered? | Vimab Group is headquartered in Sweden. |
| How many employees does Vimab Group have? | As of today, Vimab Group has over 212 employees. |
| Is Vimab Group publicly listed? | Yes, Vimab Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Vimab Group? | Vimab Group trades under VIMAB ticker. |
| When did Vimab Group go public? | Vimab Group went public in 2015. |
| Who are competitors of Vimab Group? | Vimab Group main competitors are Digital Research Company, Convalue, Dovre Group, Nepa. |
| What is the current market cap of Vimab Group? | Vimab Group's current market cap is $12M. |
| What is the current revenue of Vimab Group? | Vimab Group's last fiscal year revenue is $34M. |
| What is the current EV/Revenue multiple of Vimab Group? | Current revenue multiple of Vimab Group is 0.6x. |
| Is Vimab Group profitable? | No, Vimab Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.